Works matching DE "CYCLOOXYGENASE 2"

Results: 3985

Could Aspirin Be a Viable Adjuvant Treatment for Cancer?

Published in:: Oncology (08909091), 2011, v. 25, n. 12, p. 1235
Publication type:: Article

COX-2 Inhibitor, Celecoxib, May Prevent Lung Cancer.

Published in:: Oncology (08909091), 2011, v. 25, n. 9, p. 848
Publication type:: Article

Pre-Dx aspirin use linked to reduced PCa mortality.

Published in:

Urology Times, 2013, v. 41, n. 11, p. 16

By:

Kuznar, Wayne

Publication type:

Article

COX-2 in RP specimens strongly predicts cancer return.

Published in:

Urology Times, 2006, v. 34, n. 14, p. 6

By:

Guttman, Cheryl

Publication type:

Article

Corn Silk Induced Cyclooxygenase-2 in Murine Macrophages.

Published in:

Bioscience, Biotechnology & Biochemistry, 2005, v. 69, n. 10, p. 1848, doi. 10.1271/bbb.69.1848

By:

Kim, Kyung A.;
Hyun-Hee Shin;
Sang Kyu Choi;
Hye-Seon Choi

Publication type:

Article

COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy.

Published in:

Veterinary & Comparative Oncology, 2011, v. 9, n. 2, p. 141, doi. 10.1111/j.1476-5829.2010.00243.x

By:

Belshaw, Z.;
Constantio-Casas, F.;
Brearley, M. J.;
Dunning, M. D.;
Holmes, M. A.;
Dobson, J. M.

Publication type:

Article

Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas.

Published in:

Veterinary & Comparative Oncology, 2009, v. 7, n. 3, p. 173, doi. 10.1111/j.1476-5829.2009.00188.x

By:

Rossmeisl, J. H.;
Robertson, J. L.;
Zimmerman, K. L.;
Higgins, M. A.;
Geiger, D. A.

Publication type:

Article

Abstracts presented at the Veterinary Cancer Society Annual Conference Kansas City, Missouri, 3–6<sup>th</sup> November 2004.

Published in:: Veterinary & Comparative Oncology, 2005, v. 3, n. 3, p. 149, doi. 10.1111/j.1476-5810.2005.00077.x
Publication type:: Article

The effect of deracoxib and piroxicam on viability of canine osteosarcoma cells in vitro.

Published in:

Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 54, doi. 10.1111/j.1476-5810.2005.064ah.x

By:

Royals, S.;
Farese, J.;
Milner, R.;
Lee-Ambrose, L.

Publication type:

Article

COX-2 Expression in Feline Oral Squamous Cell Carcinoma(FOSCC)– An Immunohistochemical Study and Analysis of Survival.

Published in:

Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 44, doi. 10.1111/j.1476-5810.2005.0064t.x

By:

Hayer, A.;
Scase, T.;
Miller, J.;
Murphy, S.;
Sparkes, A.;
Adams, V.

Publication type:

Article

Expression and regulation of cyclooxygenase-2 in normal and neoplastic canine keratinocytes.

Published in:

Veterinary & Comparative Oncology, 2004, v. 2, n. 4, p. 222, doi. 10.1111/j.1476-5810.2004.00055.x

By:

Pronovost, N.;
Suter, M. M.;
Mueller, E.;
Sirois, J.;
Doré, M.

Publication type:

Article

Dual‐Targeted Nanoreactors and Prodrugs: Hydrogen Peroxide Triggers Oxidative Damage and Prodrug Activation for Synergistic Elimination of Cancer Cells.

Published in:

Advanced Functional Materials, 2022, v. 32, n. 26, p. 1, doi. 10.1002/adfm.202200791

By:

Jo, Seong‐Min;
Kim, Hyeong Seok;
Won, Miae;
Champanhac, Carole;
Kim, Jong Seung;
Wurm, Frederik R.;
Landfester, Katharina

Publication type:

Article

Intracellular Bottom‐up Synthesis of Ultrasmall CuS Nanodots in Cancer Cells for Simultaneous Photothermal Therapy and COX‐2 Inactivation.

Published in:

Advanced Functional Materials, 2021, v. 31, n. 27, p. 1, doi. 10.1002/adfm.202101297

By:

Feng, Liandong;
Wu, Shanshan;
Wu, Yuzhou

Publication type:

Article

Role of cyclooxygenase-2 functional gene polymorphisms in Helicobacter pylori induced gastritis and gastric atrophy.

Published in:

Molecular & Cellular Biochemistry, 2009, v. 321, n. 1/2, p. 103, doi. 10.1007/s11010-008-9924-0

By:

B. Achyut;
Uday Ghoshal;
Nikhil Moorchung;
Balraj Mittal

Publication type:

Article

shRNA-targeted Cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells.

Published in:

Molecular & Cellular Biochemistry, 2008, v. 317, n. 1/2, p. 179, doi. 10.1007/s11010-008-9847-9

By:

Rui Wang;
Xi Wang;
Fang Lin;
Ping Gao;
Ke Dong;
Hui-Zhong Zhang

Publication type:

Article

Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma.

Published in:

Molecular & Cellular Biochemistry, 2008, v. 313, n. 1/2, p. 53

By:

Gopalakrishnan Ramakrishnan;
Carmen Elinos-Báez;
Sundaram Jagan;
Titto Augustine;
Sattu Kamaraj;
Pandi Anandakumar;
Thiruvengadam Devaki

Publication type:

Article

Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival.

Published in:

Molecular & Cellular Biochemistry, 2007, v. 295, n. 1, p. 75, doi. 10.1007/s11010-006-9275-7

By:

Marina Perdiki;
Penelope Korkolopoulou;
Irene Thymara;
George Agrogiannis;
Christina Piperi;
Efstathios Boviatsis;
Xenophon Kotsiakis;
Dimitrios Angelidakis;
Kalliopi Diamantopoulou;
Euphemia Thomas-Tsagli;
Efstratios Patsouris

Publication type:

Article

QSAR and classification models of a novel series of COX-2 selective inhibitors: 1, 5-diarylimidazoles based on support vector machines.

Published in:

Journal of Computer-Aided Molecular Design, 2004, v. 18, n. 6, p. 389, doi. 10.1007/s10822-004-2722-1

By:

Liu, H. X.;
Zhang, R. S.;
Yao, X. J.;
Liu, M. C.;
Hu, Z. D.;
Fan, B. T.

Publication type:

Article

Tempo and Mode in the Endocannaboinoid System.

Published in:

Journal of Molecular Evolution, 2007, v. 65, n. 3, p. 267, doi. 10.1007/s00239-007-9004-1

By:

McPartland, John M.;
Norris, Ryan W.;
Kilpatrick, C. William

Publication type:

Article

COX-2-Selective NSAIDs and Risk of Hip or Knee Replacements: A Population-Based Case-Control Study.

Published in:

Calcified Tissue International, 2012, v. 91, n. 6, p. 387, doi. 10.1007/s00223-012-9646-x

By:

Klop, Corinne;
Vries, Frank;
Lalmohamed, Arief;
Mastbergen, Simon;
Leufkens, Hubert;
Noort-van der Laan, Willemijn;
Bijlsma, Johannes;
Welsing, Paco

Publication type:

Article

Marrow Stromal Cell-Based Cyclooxygenase 2 Ex Vivo Gene-Transfer Strategy Surprisingly Lacks Bone-Regeneration Effects and Suppresses the Bone-Regeneration Action of Bone Morphogenetic Protein 4 in a Mouse Critical-Sized Calvarial Defect Model.

Published in:

Calcified Tissue International, 2009, v. 85, n. 4, p. 356, doi. 10.1007/s00223-009-9282-2

By:

Lau, K.-H. William;
Gysin, Reinhard;
Shin-Tai Chen;
Wergedal, Jon E.;
Baylink, David J.;
Mohan, Subburaman

Publication type:

Article

Histamine, carbachol, and serotonin induce hyperresponsiveness to ATP in guinea pig tracheas: involvement of COX-2 pathway.

Published in:

Pflügers Archiv: European Journal of Physiology, 2013, v. 465, n. 8, p. 1171, doi. 10.1007/s00424-013-1253-9

By:

Montaño, Luis;
Carbajal, Verónica;
Vargas, Mario;
García-Hernández, Luz;
Díaz-Hernández, Verónica;
Checa, Marco;
Barajas-López, Carlos

Publication type:

Article

Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes.

Published in:

Pflügers Archiv: European Journal of Physiology, 2008, v. 455, n. 6, p. 971, doi. 10.1007/s00424-007-0346-8

By:

Li-Fang Hu;
Ting-Ting Pan;
Kay Li Neo;
Qian Chen Yong;
Jin-Song Bian

Publication type:

Article

Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression.

Published in:

Pflügers Archiv: European Journal of Physiology, 2001, v. 442, n. 6, p. 842, doi. 10.1007/s004240100616

By:

Kammerl, Martin C.;
Nüsing, Rolf M.;
Seyberth, Hannsjörg W.;
Riegger, Günter A.;
Kurtz, Armin;
Krämer, Bernhard K.

Publication type:

Article

Sepsis in rats: Effects of inhibitors of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-2).

Published in:: 2000
Publication type:: Abstract

Upregulation of cyclooxygenase-2 expression in the macula densa by inhibition of the renin angiotensin system.

Published in:: 2000
Publication type:: Abstract

Cox-2 derived prostaglandins do not mediate the stimulation of the renin system by converting enzyme inhibition.

Published in:: 2000
Publication type:: Abstract

Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.

Published in:

2016

By:

Winkler, Sebastian;
Springorum, Hans-Robert;
Vaitl, Tobias;
Handel, Martin;
Barta, Sabine;
Kehl, Victoria;
Craiovan, Benjamin;
Grifka, Joachim

Publication type:

journal article

Effectiveness of paracetamol-NSAID combinations for upper and lower respiratory tract infections: a preliminary evaluation in primary care.

Published in:

2024

By:

Lapi, Francesco;
Marconi, Ettore;
Aprile, Pierangelo Lora;
Rossi, Alessandro;
Fornasari, Diego;
Cricelli, Claudio

Publication type:

Letter

What about COVID-19 and arachidonic acid pathway?

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 11, p. 1501, doi. 10.1007/s00228-020-02941-w

By:

Hoxha, Malvina

Publication type:

Article

Response by Pei et al. to letters regarding article, "Pharmacokinetic study of imrecoxib in patients with renal insufficiency".

Published in:

2020

By:

Pei, Qi;
Xie, Jin-lian;
Zhang, Hao;
Yang, Guo-Ping

Publication type:

Letter to the Editor

Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients.

Published in:

2020

By:

Srinivas, Nuggehally R.

Publication type:

Letter to the Editor

Pharmacokinetic study of imrecoxib in patients with renal insufficiency.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 10, p. 1355, doi. 10.1007/s00228-019-02698-x

By:

Pei, Qi;
Xie, Jin-lian;
Huang, Jie;
Liu, Wen-yu;
Yang, Xiao-yan;
Wang, Yan;
Li, Wei;
Tan, Hong-yi;
Zhang, Hao;
Yang, Guo-Ping

Publication type:

Article

Impact of drugs on venous thromboembolism risk in surgical patients.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 6, p. 751, doi. 10.1007/s00228-019-02636-x

By:

Kovačič, Alenka Premuš Marušič;
Caprnda, Martin;
Mrhar, Aleš;
Kubatka, Peter;
Locatelli, Igor;
Zolakova, Barbora;
Gaspar, Ludovit;
Prosecky, Robert;
Kruzliak, Peter;
Staffa, Robert;
Rodrigo, Luis;
Radonak, Jozef;
Petrovič, Danijel

Publication type:

Article

Effectiveness of an academic detailing intervention in primary care on the prescribing of non-steroidal anti-inflammatory drugs.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 4, p. 577, doi. 10.1007/s00228-018-02611-y

By:

Langaas, Harald Chr.;
Hurley, Eimir;
Dyrkorn, Roar;
Spigset, Olav

Publication type:

Article

High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 3, p. 549, doi. 10.1007/s00228-012-1334-2

By:

Garbe, E.;
Kloss, S.;
Suling, M.;
Pigeot, I.;
Schneeweiss, S.

Publication type:

Article

Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 2, p. 179, doi. 10.1007/s00228-011-1105-5

By:

Franz, Carmen;
Egger, Sabin;
Born, Christa;
Rätz Bravo, Alexandra;
Krähenbühl, Stephan

Publication type:

Article

Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo.

Published in:

European Journal of Clinical Pharmacology, 2008, v. 64, n. 5, p. 511, doi. 10.1007/s00228-007-0456-4

By:

Karjalainen, Marjo;
Neuvonen, Pertti;
Backman, Janne T.

Publication type:

Article

COX-2 inhibitors and arterial hypertension: an analysis of spontaneous case reports in the Pharmacovigilance database.

Published in:

European Journal of Clinical Pharmacology, 2005, v. 61, n. 8, p. 611, doi. 10.1007/s00228-005-0964-z

By:

Durrieu, G.;
Olivier, P.;
Montastruc, J. L.

Publication type:

Article

"Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs.

Published in:

European Journal of Clinical Pharmacology, 2003, v. 59, n. 8/9, p. 645, doi. 10.1007/s00228-003-0661-8

By:

Bennett, Kathleen;
Teeling, Mary;
Feely, John

Publication type:

Article

Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.

Published in:

European Journal of Clinical Pharmacology, 2003, v. 59, n. 2, p. 169, doi. 10.1007/s00228-003-0579-1

By:

Gomez Cerezo, Jorge;
Lubomirov Hristov, Rubin;
Carcas Sansuán, Antonio J.;
Vázquez Rodríguez, Juan J.

Publication type:

Article

Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma.

Published in:

2017

By:

Cai, Shengnan;
Zhang, Yue-xiang;
Han, Ke;
Ding, Yi-qian

Publication type:

journal article

Evaluation of the frequency of G-765C polymorphism in the promoter region of the COX-2 gene and its correlation with the expression of this gene in the endometrium of women with endometriosis.

Published in:

2016

By:

Cavalcanti, Viviane;
Ponce, Tatiana;
Mafra, Fernanda;
André, Gustavo;
Christofolini, Denise;
Barbosa, Caio;
Bianco, Bianca;
Ponce, Tatiana Guida;
Mafra, Fernanda Abani;
André, Gustavo Mendonça;
Christofolini, Denise Maria;
Barbosa, Caio Parente

Publication type:

journal article

Effect of mifepristone on COX-2 both in eutopic and ectopic endometrium in mouse endometriotic model.

Published in:

Archives of Gynecology & Obstetrics, 2012, v. 286, n. 4, p. 939, doi. 10.1007/s00404-012-2379-2

By:

Li, Xiujuan;
Bao, Yanyan;
Fang, Peng;
Chen, Yaping;
Qiao, Zhongdong

Publication type:

Article

COX-2 and Her-2/neu are overexpressed in Paget’s disease of the vulva and the breast: results of a preliminary study.

Published in:

Archives of Gynecology & Obstetrics, 2008, v. 277, n. 2, p. 135, doi. 10.1007/s00404-007-0434-1

By:

Horn, Lars-Christian;
Purz, Sandra;
Krumpe, Christine;
Bilek, Karl

Publication type:

Article

A comparative study of the effect of rofecoxib (a COX 2 inhibitor) and naproxen sodium on analgesic requirements after abdominal hysterectomy.

Published in:

Archives of Gynecology & Obstetrics, 2003, v. 268, n. 4, p. 297, doi. 10.1007/s00404-002-0377-5

By:

Çelik, Jale Bengi;
Tuncer, Sema;
Reisli, Ruhiye;
Sarkιlar, Gamze;
Çelik, Çetin;
Akyürek, Cemalettin

Publication type:

Article

MDR1 Single Nucleotide Polymorphisms Predict Response to Vinorelbine-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer.

Published in:

Respiration, 2008, v. 75, n. 4, p. 380, doi. 10.1159/000108407

By:

Ji-hong Pan;
Jin-xiang Han;
Jian-mei Wu;
Li-jun Sheng;
Hai-nan Huang;
Qing-zhong Yu

Publication type:

Article

Expression of COX-2 in Stomach Cancers and Its Relation to Their Biological Features.

Published in:

Digestive Surgery, 2003, v. 20, n. 2, p. 107, doi. 10.1159/000069384

By:

Shao-Liang Han;
Huai-Jing Tang;
Ya-Wei Hua;
She-Qing Ji;
Dong-Xin Lin

Publication type:

Article

Synthesis of Chalcone Derivatives as COX-2 Inhibitory Activity for Ischemic Stroke Treatment.

Published in:

Chemistry of Natural Compounds, 2024, v. 60, n. 1, p. 13, doi. 10.1007/s10600-024-04241-6

By:

Jiao, Feitong;
Song, Yuan;
Wang, Xinxin;
Zhang, Tianyi

Publication type:

Article

Screening of Ursolic Acid Analogs with HIF-1α and COX-2-Inhibiting Effects.

Published in:

Chemistry of Natural Compounds, 2022, v. 58, n. 5, p. 882, doi. 10.1007/s10600-022-03821-8

By:

Li, Chunshi;
Zhang, Tianyi;
Zhang, Qiaosi;
Liu, Xin;
Zou, Jixin;
Bai, Xueqian

Publication type:

Article